ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2018 American Transplant Congress

    Complex Combined Thoracic/liver Transplant: A Seven Year Experience

    N. Presser, J. DiNorcia, V. Agopian, H. Yersiz, D. Farmer, R. Busuttil, F. Kaldas.

    Liver and Pancreas Transplant, UCLA, Los Angeles, CA.

    Background: While rare, combined Thoracic/Liver transplants are employed with increasing frequency. Consistent data regarding the technical conduct, patient selection and outcomes in this highly complex…
  • 2018 American Transplant Congress

    The Role of CD46 in Early Islet Engraftment in a Dual Transplant Model

    Q. Gao, K. Samy, R. Davis, M. Song, A. MacDonald, F. Leopardi, T. How, K. Williams, G. Devi, B. Collins, A. Kirk.

    Department of Surgery, Duke University School of Medicine, Durham, NC.

    IntroductionMembrane cofactor protein (CD46) is known to attenuate the complement cascade by facilitating cleavage of C3b and C4b. In solid organ xenotransplantation, organs expressing CD46…
  • 2018 American Transplant Congress

    Recurrence of Immunoglobulin A Nephropathy in Related Donor Kidney Transplant Recipients

    M. Okumi,1 D. Okada,1 K. Unagami,2 Y. Kakuta,1 H. Shirakawa,3 T. Shimizu,4 K. Omoto,4 H. Ishida,1 K. Tanabe.1

    1Urology, Toyko Women's Medical University, Tokyo, Japan; 2Nephrology, Toyko Women's Medical University, Tokyo, Japan; 3Urology, Ohkubo Hospital, Tokyo, Japan; 4Urology, Toda Chuo General Hospital, Saitama, Japan.

    BackgroundSecondary to an increase in the graft survival rates in patients undergoing successful kidney transplantation, an increase in the occurrence of recurrent glomerulonephritis has been…
  • 2018 American Transplant Congress

    Belatacept in Kidney Transplant Recipients with Preformed Donor Specific Anti-HLA Antibodies: Results of the BELACOR Trial

    C. Leibler,1 F. Canoui,2 M. Matignon,1 E. Rondeau,3 A. Zarour,2 A. Durrbach,4 S. Malard,5 P. Grimbert.1

    1Nephrology Transplantation, APHP Henri Mondor, Creteil, France; 2Public Health, APHP Henri Mondor, Creteil, France; 3Nephrology Transplantation, APHP Tenon, Paris, France; 4Nephrology Transplantation, APHP Bicêtre, Le Kremlin Bicêtre, France; 5Histocompatibility, APHP Saint Louis, Paris, France.

    IntroductionAntibody-mediated rejection (ABMR) is currently a critical question in kidney transplant recipient with immunological risk factors such as pre transplant donor-specific anti HLA antibodies (DSA).…
  • 2018 American Transplant Congress

    Longitudinal Analysis of Community Respiratory Virus Infection in Kidney Transplant Recipients

    O. Beaird, K. Phonphok, S. Chandrasekaran, O. Garner, S. Bunnapradist, J. Schaenman.

    David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA.

    Purpose: Community respiratory viruses (CRVs) cause significant morbidity and mortality in solid organ transplant recipients, but little is known about the epidemiology of CRV infections…
  • 2018 American Transplant Congress

    Kidney Registration Volume vs. Expectation: Impact of ESRD Burden and Outreach

    A. Wilk, R. Urban, R. Carrico.

    United Network for Organ Sharing, Richmond, VA.

    Overall trends in waiting list registrations prior to KAS have predominately monotonically increased, albeit with varied rates of growth, since 2000. However, as a result…
  • 2018 American Transplant Congress

    Outcomes of C4d+ Immunostaining in Heart Transplantation: Is All Immunologic AMR Bad?

    M. Rafiei, J. Patel, E. Kransdorf, R. Levine, S. Dimbil, S. Mersola, G. Esmailian, D. Geft, D. Chang, L. Czer, J. Kobashigawa.

    Cedars Sinai Medical Center, Los Angeles, CA.

    Purpose: Antibody-mediated rejection (AMR) remains a threat to patients (pts) following heart transplant (HTx). C4d immunostaining is one component involved in the diagnosis of AMR…
  • 2018 American Transplant Congress

    Kidney Transplant Allocation with CMV Seromatching Reduces CMV Infection without Affecting Wait Times

    A. Narra,1 L. Strasfeld,2 D. Basuli,1 M. Stack,1 E. Langewisch,3 A. Olyaei,1 D. Norman,1,4 J. Lockridge.1,4

    1Transplant Nephrology, Oregon Health and Science University, Portland, OR; 2Infectious Diseases, OHSU, Portland, OR; 3Transplant Nephrology, University of Nebraska Medical Center, Omaha, NE; 4Transplant Nephrology, Portland VA, Portland, OR.

    Cytomegalovirus (CMV) infection is a major cause of morbidity and mortality in kidney transplant recipients.A pre-transplant allocation strategy by matching deceased kidney donors and recipients…
  • 2018 American Transplant Congress

    One-Pump versus Two-Pump Normothermic Ex Vivo Perfusion Machines in Discarded Human Livers

    A. Hassan, Q. Liu, D. Pezzati, A. Nassar, B. Soliman, M. Blum, P. Grady, G. Iuppa, T. Uso, J. Fung, K. Abu-Elmagd, C. Quintini.

    Transplant Surgery, Cleveland Clinic, Cleveland.

    Introduction:Physiologic flows and pressures need to be provided by the ex vivo liver perfusion device. We hypothesized that the 1-pump designed machines would provide the…
  • 2018 American Transplant Congress

    Deceased Donor Urinary Biomarker Signature and the Effectiveness of Peritransplant Lymphocyte Depletion on Early Renal Allograft Function

    S. Bernd,2 P. Heeger,1 T-.P. Heather,3 I. Hall,7 M. Doshi,4 F. Weng,5 P. Reese,6 C. Parikh.3

    1Icahn School of Medicine Mount Sinai, New York, NY; 2University of Ulm, Ulm, Germany; 3Yale University School of Medicine, New Haven, CT; 4Wayne State University, Detroit, MI; 5Barnabas Health, Livingston, NJ; 6University of Pennsylvania, Philadelphia, PA; 7University of Utah School of Medicine, Salt Lake City, UT.

    Purpose: Delayed graft function (DGF) is associated with increased allogaft immunogenicity and decreased long-term survival. We hypothesized that high levels of donor urinary biomarkers for…
  • « Previous Page
  • 1
  • …
  • 163
  • 164
  • 165
  • 166
  • 167
  • …
  • 211
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2026 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences